Mark Gregory Goldstein

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

University of California, Los Angeles(Current)

Mark Gregory Goldstein is an author at University of California, Los Angeles specializing in immunotherapy, cd8 t cell activation, and messenger ribonucleic acid neoantigen vaccines.

Publications per year

2022–2022

Publications

Phase 2/3, randomized, open-label study of an individualized neoantigen vaccine (self-amplifying mRNA and adenoviral vectors) plus immune checkpoint blockade as maintenance for patients with newly diagnosed metastatic colorectal cancer (GRANITE).

J. Randolph Hecht, Ardaman Shergill, Mark Gregory Goldstein et al. · Journal of Clinical Oncology · 2022 · 17 citations

Life Sciences, Immunology, Pharmacology +17

1–1 of 1